ArticleNucleic acids research2025
Elucidating the role of mycobacteriophage D29-encoded Gp36 in DNA binding and phage gene expression regulation.
Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Computational prediction resolves thousands of homooligomeric phage protein structures.bioRxiv : the preprint server for biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Bacteriophage infection leading to progeny production in a bacterial host requires timely expression of phage genes that is regulated by various phage- and bacteria-encoded factors. Mycobacteriophage D29, a lytic bacteriophage, is capable of infecting several mycobacterial species, including pathogenic Mycobacterium tuberculosis. Genomic characterization of D29 revealed two distinct promoters present at extreme ends of the genome that govern expression of phage genes. However, D29-derived transcriptional factors that regulate such expression remain largely unexplored. Here, we have characterized D29-encoded Gp36. We show that Gp36 binds to GC-rich direct repeats in sequence-specific manner. Gp36 makes weak homo-oligomer in vitro, with residues I25 and L35 being important for homo-oligomerization. We further show that Gp36 belongs to MerR family of transcriptional regulators, and represses expression of D29 genes; bacteriophage lacking gp36 shows higher expression of those early and late genes that are downstream to the Gp36 binding site in the genome. Such alteration of gene expression in mutated phage resulted in lower phage titer, although plaque size and host lysis timing remained unaltered. We thus present Gp36 as a transcriptional repressor of D29 with a regulatory role in modulating D29 gene expression, and envisage its engineering as a potential approach for developing phage therapeutics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.